Clinical Trials Browser

Phase 2 × Waldenstrom Macroglobulinemia × acalabrutinib × Clear all

NCT02180724 2026-03-20

An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia

Phase 2 Active not recruiting

107 enrolled 15 charts

Waldenstrom Macroglobulinemia

NCT04624906 2026-02-04

BRAWM

Phase 2 Active not recruiting

Waldenstrom Macroglobulinemia

NCT05065554 2025-12-05

ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy

Phase 2 Active not recruiting

Waldenstrom Macroglobulinemia, Neuritis